These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31032225)

  • 1. High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer.
    Zhao H; Yu M; Sui L; Gong B; Zhou B; Chen J; Gong Z; Hao C
    Front Oncol; 2019; 9():262. PubMed ID: 31032225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPDC1 upregulation promotes cell proliferation and predicts poor prognosis in patients with gastric cancer.
    Gong Z; Chu H; Chen J; Jiang L; Gong B; Zhu P; Zhang C; Wang Z; Zhang W; Wang J; Li C; Zhao H
    Cancer Biomark; 2021; 30(3):299-307. PubMed ID: 33361586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma.
    Feng X; Zhang C; Zhu L; Zhang L; Li H; He L; Mi Y; Wang Y; Zhu J; Bu Y
    Oncotarget; 2017 Sep; 8(38):63605-63619. PubMed ID: 28969015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression.
    Zhu C; Ke S; Li Y; Zhang W; Che Y; Zhang R; Huang P; Xu T
    Heliyon; 2024 Mar; 10(5):e27150. PubMed ID: 38449652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.
    Huang L; Chen K; Cai ZP; Chen FC; Shen HY; Zhao WH; Yang SJ; Chen XB; Tang GX; Lin X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):707-712. PubMed ID: 28634077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma.
    Li C; Zhu X
    Heliyon; 2024 May; 10(9):e30642. PubMed ID: 38765113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NNK-mediated upregulation of DEPDC1 stimulates the progression of oral squamous cell carcinoma by inhibiting CYP27B1 expression.
    Guo J; Zhou S; Huang P; Xu S; Zhang G; He H; Zeng Y; Xu CX; Kim H; Tan Y
    Am J Cancer Res; 2020; 10(6):1745-1760. PubMed ID: 32642287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
    Lv M; Li X; Yin Z; Yang H; Zhou B
    PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
    Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
    Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
    Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of
    Jia B; Liu J; Hu X; Xia L; Han Y
    Ann Transl Med; 2022 Dec; 10(24):1355. PubMed ID: 36660720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEP domain containing 1 suppresses apoptosis via inhibition of A20 expression, which activates the nuclear factor κB signaling pathway in HepG2 cells.
    Li A; Wang Q; He G; Jin J; Huang G
    Oncol Lett; 2018 Jul; 16(1):949-955. PubMed ID: 29963168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway.
    Wang Q; Li A; Jin J; Huang G
    Onco Targets Ther; 2017; 10():4443-4454. PubMed ID: 28979136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEPDC1 as a crucial factor in the progression of human osteosarcoma.
    Shen L; Li H; Liu R; Zhou C; Bretches M; Gong X; Lu L; Zhang Y; Zhao K; Ning B; Yang SY; Zhang A
    Cancer Med; 2023 Mar; 12(5):5798-5808. PubMed ID: 36479633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
    Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
    J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1.
    Sharen G; Li X; Sun J; Zhang L; Xi W; Zhao X; Han F; Jia L; A R; Cheng H; Hou M
    J Transl Med; 2022 Oct; 20(1):493. PubMed ID: 36309731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
    Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
    Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEPDC1 is a novel cell cycle related gene that regulates mitotic progression.
    Mi Y; Zhang C; Bu Y; Zhang Y; He L; Li H; Zhu H; Li Y; Lei Y; Zhu J
    BMB Rep; 2015 Jul; 48(7):413-8. PubMed ID: 25902835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.